Organization
University of Foggia, Foggia, Italy
2 abstracts
Abstract
Real-life use of cabozantinib as front-line therapy in metastatic renal cell carcinoma: The CabFRONT (Meet-URO 24) study.Org: Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, Department of Health Sciences, University of Florence, Florence, Italy, Medical Oncology Unit 1, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy, Oncology Unit, Foundation Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Italy,
Abstract
BIOMARKERS OF CLINICAL RESPONSE TO IL6-R BLOCKADE IN DMARDS INCOMPLETE RESPONDERS (AR-BIOM TRIAL): IL23 AND BAFF AS BIOLOGICAL TARGETS, AND ALBUMIN AS BIOLOGICAL PREDICTOROrg: Università Cattolica del Sacro Cuore, Division of Rheumatology, Rome, Italy, Fondazione Policlinico Universitario A. Gemelli IRCCS, Division of Rheumatology, Rome, Italy, University of Bari, Bari, Italy, University of Verona, Verona, Italy, L. Sacco University Hospital, Milan, Italy,